Search hospitals > Wisconsin > Minocqua
Marshfield Clinic-Minocqua Center
Claim this profileMinocqua, Wisconsin 54548
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
307 reported clinical trials
24 medical researchers
Summary
Marshfield Clinic-Minocqua Center is a medical facility located in Minocqua, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Marshfield Clinic-Minocqua Center is involved with conducting 307 clinical trials across 459 conditions. There are 24 research doctors associated with this hospital, such as Seth O. Fagbemi, Adedayo A. Onitilo, Chady A. Leon, MD, and Demet Gokalp Yasar.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
Top PIs
Seth O. FagbemiMarshfield Medical Center-EC Cancer Center4 years of reported clinical research
Studies Cancer
Studies Prostate Cancer
33 reported clinical trials
80 drugs studied
Adedayo A. OnitiloMarshfield Medical Center - Weston1 year of reported clinical research
Studies Cancer
Studies Lung Cancer
21 reported clinical trials
82 drugs studied
Chady A. Leon, MDMarshfield Medical Center-Marshfield5 years of reported clinical research
Studies Lymphoma
Studies Leukemia
18 reported clinical trials
56 drugs studied
Demet Gokalp YasarMarshfield Medical Center-EC Cancer Center4 years of reported clinical research
Studies Cancer
Studies Breast Cancer
13 reported clinical trials
31 drugs studied
Clinical Trials running at Marshfield Clinic-Minocqua Center
Breast Cancer
Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Lung Cancer
Squamous Cell Carcinoma
Bladder Carcinoma
Renal Cell Carcinoma
Multiple Myeloma
Hormone Therapy with or without Radiation
for Breast Cancer
This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Marshfield Clinic-Minocqua Center?
Marshfield Clinic-Minocqua Center is a medical facility located in Minocqua, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Marshfield Clinic-Minocqua Center is involved with conducting 307 clinical trials across 459 conditions. There are 24 research doctors associated with this hospital, such as Seth O. Fagbemi, Adedayo A. Onitilo, Chady A. Leon, MD, and Demet Gokalp Yasar.